Cambridge Investment Research Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-14,573
| Closed | -$2.68M | – | 3266 |
|
|
2021
Q2 | $2.68M | Buy |
14,573
+410
| +3% | +$75.3K | 0.01% | 959 |
|
|
2021
Q1 | $2.17M | Buy |
14,163
+3,787
| +36% | +$579K | 0.01% | 966 |
|
|
2020
Q4 | $1.62M | Buy |
10,376
+692
| +7% | +$108K | 0.01% | 1043 |
|
|
2020
Q3 | $1.11M | Sell |
9,684
-280
| -3% | -$32K | 0.01% | 1125 |
|
|
2020
Q2 | $1.12M | Sell |
9,964
-806
| -7% | -$90.4K | 0.01% | 1062 |
|
|
2020
Q1 | $967K | Buy |
10,770
+1,742
| +19% | +$156K | 0.01% | 995 |
|
|
2019
Q4 | $976K | Sell |
9,028
-310
| -3% | -$33.5K | 0.01% | 1161 |
|
|
2019
Q3 | $915K | Buy |
9,338
+1,834
| +24% | +$180K | 0.01% | 1122 |
|
|
2019
Q2 | $983K | Buy |
7,504
+731
| +11% | +$95.8K | 0.01% | 1033 |
|
|
2019
Q1 | $916K | Buy |
6,773
+4,069
| +150% | +$550K | 0.01% | 1079 |
|
|
2018
Q4 | $263K | Sell |
2,704
-313
| -10% | -$30.4K | ﹤0.01% | 1746 |
|
|
2018
Q3 | $419K | Buy |
3,017
+722
| +31% | +$100K | ﹤0.01% | 1551 |
|
|
2018
Q2 | $285K | Sell |
2,295
-13
| -0.6% | -$1.61K | ﹤0.01% | 1765 |
|
|
2018
Q1 | $257K | Sell |
2,308
-1,158
| -33% | -$129K | ﹤0.01% | 1786 |
|
|
2017
Q4 | $414K | Sell |
3,466
-1,094
| -24% | -$131K | ﹤0.01% | 1434 |
|
|
2017
Q3 | $640K | Sell |
4,560
-1,002
| -18% | -$141K | 0.01% | 1098 |
|
|
2017
Q2 | $677K | Buy |
+5,562
| New | +$677K | 0.01% | 1018 |
|
|
2016
Q4 | – | Sell |
-3,416
| Closed | -$419K | – | 1838 |
|
|
2016
Q3 | $419K | Buy |
+3,416
| New | +$419K | 0.01% | 1132 |
|
|
2016
Q2 | – | Sell |
-3,893
| Closed | -$542K | – | 1695 |
|
|
2016
Q1 | $542K | Sell |
3,893
-777
| -17% | -$108K | 0.01% | 851 |
|
|
2015
Q4 | $891K | Buy |
+4,670
| New | +$891K | 0.02% | 592 |
|
|
2015
Q3 | – | Sell |
-3,227
| Closed | -$583K | – | 1613 |
|
|
2015
Q2 | $583K | Sell |
3,227
-114
| -3% | -$20.6K | 0.02% | 736 |
|
|
2015
Q1 | $579K | Buy |
3,341
+79
| +2% | +$13.7K | 0.02% | 718 |
|
|
2014
Q4 | $604K | Buy |
3,262
+60
| +2% | +$11.1K | 0.02% | 686 |
|
|
2014
Q3 | $531K | Buy |
3,202
+210
| +7% | +$34.8K | 0.02% | 798 |
|
|
2014
Q2 | $468K | Buy |
2,992
+30
| +1% | +$4.69K | 0.02% | 784 |
|
|
2014
Q1 | $451K | Sell |
2,962
-1,307
| -31% | -$199K | 0.02% | 759 |
|
|
2013
Q4 | $567K | Sell |
4,269
-1,001
| -19% | -$133K | 0.02% | 603 |
|
|
2013
Q3 | $612K | Sell |
5,270
-9,798
| -65% | -$1.14M | 0.03% | 536 |
|
|
2013
Q2 | $1.39M | Buy |
+15,068
| New | +$1.39M | 0.07% | 251 |
|